Quizartinib Dihydrochloride
Records for this ingredient, by country (identity only).
ATC — · 3 markets · 6 records
TW 2 records · 2 shown of 2
- 26.5 mgtabletVanflyta F.C. Tablets 17.7 mg維復泰膜衣錠26.5毫克
- 17.7 mgtabletVanflyta F.C. Tablets 17.7 mg維復泰膜衣錠17.7毫克
FR 2 records · 2 shown of 2
- 26.5 mgtabletVANFLYTA 17,7 mg, comprimé pelliculé
- 17.7 mgtabletVANFLYTA 17,7 mg, comprimé pelliculé
| Strength / form / release | US | TW | FR |
|---|---|---|---|
| 26.5 mg tablet | VANFLYTA | Vanflyta F.C. Tablets 17.7 mg 維復泰膜衣錠26.5毫克 | VANFLYTA 17,7 mg, comprimé pelliculé |
| 17.7 mg tablet | VANFLYTA | Vanflyta F.C. Tablets 17.7 mg 維復泰膜衣錠17.7毫克 | VANFLYTA 17,7 mg, comprimé pelliculé |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.